7115 9 3
Pill imprint 7115 9 3 has been identified as Paroxetine hydrochloride 20 mg.
Paroxetine is used in the treatment of anxiety; depression; anxiety and stress; generalized anxiety disorder; obsessive compulsive disorder (and more), and belongs to the drug class selective serotonin reuptake inhibitors. There is positive evidence of human fetal risk during pregnancy.
Paroxetine 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Paroxetine hydrochloride Images
- Imprint:
-
7115
9 3 - Strength:
- 20 mg
- Color:
- Pink
- Size:
- 7.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- calcium phosphate
hypromelloses
magnesium stearate
polyethylene glycol
polysorbate 80
povidone
sodium starch glycolate type A potato
titanium dioxide
FD&C Red No. 40
aluminum oxide
- Drug Class:
- Selective serotonin reuptake inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-7115
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0774 | UDL Laboratories Inc |
Note: Inactive ingredients may vary.
Advertisement
More Paroxetine Hydrochloride resources
- Paroxetine
- Paroxetine (Wolters Kluwer)
- Paroxetine Controlled-Release Tablets (Wolters Kluwer)
- Paroxetine Mesylate (Wolters Kluwer)
- Paroxetine Suspension (Wolters Kluwer)
- paroxetine (Cerner Multum)
- paroxetine (Micromedex) - Includes Dosage Information
- Paroxetine Hydrochloride (AHFS DI)
- Paroxetine (FDA)
- Paroxetine ER (FDA)
- Paroxetine Oral Suspension (FDA)
- Paroxetine (Wolters Kluwer)
Search Again
